Diltiazem Market is expected to reach US$ 832.51 Mn by 2028

Published Date: 12 Aug 2021

Report : Diltiazem Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Tablet, Capsule, Injection); Application (Angina, Hypertension, Others)

Consumables Segment to Lead Diltiazem Market During 2021–2028

According to our new research study on “Diltiazem Market to 2028 – Global Analysis and Forecast – by Product Type, Application, and Geography,” the diltiazem market is projected to reach US$ 832.51 million by 2028 from US$ 369.95 million in 2021; it is expected to grow at a CAGR of 12.3% during 2021–2028. The growth of the market is attributed to rising prevalence of cardiovascular disease, growing geriatric population are driving the market growth.
           
Based on product type, the diltiazem market is segmented into capsules, injection, and tablets. In 2021, the tablets segment held the largest share of the market, whereas the capsules segment is expected to witness the fastest CAGR during the forecast period. Factors such as increase in cardiovascular disease incidence and increasing elderly population are driving the market growth. However, side effects of diltiazem is likely to hamper the growth of the market.

Bausch Health; Teva Pharmaceutical Industries Ltd; Mylan N.V; Athenex; Pfizer, Inc; Glenmark; Sandoz (Novartis Ag); Sun Pharmaceutical Company Ltd; Hikma Pharmaceuticals; and Zydus Pharmaceuticals among the leading companies operating in the diltiazem market.

Diltiazem Market, by Region, 2021 (%)
Diltiazem Market, by Region, 2021 (%)

The Report Segments Diltiazem Market as Follows:
The diltiazem market is segmented based on product type and end user. Based on product type, In 2021, the tablets segment held the largest share of the market, by product type. However , the capsules segment of Diltiazem Market is also expected to witness fastest CAGR during 2021 to 2028. Based on application the market is segmented into angina, hypertension, and others. In 2021, the hypertension segment held the largest share of the market, by application. Whereas the Angina segment is expected to grow at the fastest CAGR during the coming years.
 
By Geography
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of APAC
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
Download Free PDF Brochure